Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Meet Ashanti Finley, Specialist in the People Function team at Berkeley Heights, US. Hear what she has to say about life at Hikma. #OwnYourCareer Story, Life at Hikma 06 June 2025 Meet Ashanti Finley, Specialist in the People Function team at Berkeley Heights, US. Hear what she has to say about life at Hikma. #OwnYourCareer
- Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement Story, Leadership 05 June 2025 Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement
- Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US Press Release, Product 05 June 2025 Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US
- Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable Press Release, Corporate 29 May 2025 Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable
Related content